1055 related articles for article (PubMed ID: 23846904)
21. Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers.
Pittoni P; Tripodo C; Piconese S; Mauri G; Parenza M; Rigoni A; Sangaletti S; Colombo MP
Cancer Res; 2011 Sep; 71(18):5987-97. PubMed ID: 21896641
[TBL] [Abstract][Full Text] [Related]
22. Local and systemic protumorigenic effects of cancer-associated fibroblast-derived GDF15.
Bruzzese F; Hägglöf C; Leone A; Sjöberg E; Roca MS; Kiflemariam S; Sjöblom T; Hammarsten P; Egevad L; Bergh A; Ostman A; Budillon A; Augsten M
Cancer Res; 2014 Jul; 74(13):3408-17. PubMed ID: 24780757
[TBL] [Abstract][Full Text] [Related]
23. Syndecan-1 (CD138) contributes to prostate cancer progression by stabilizing tumour-initiating cells.
Shimada K; Anai S; Fujii T; Tanaka N; Fujimoto K; Konishi N
J Pathol; 2013 Dec; 231(4):495-504. PubMed ID: 24549646
[TBL] [Abstract][Full Text] [Related]
24. Survey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis.
Kasper S
J Cell Biochem; 2005 Feb; 94(2):279-97. PubMed ID: 15565647
[TBL] [Abstract][Full Text] [Related]
25. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
[TBL] [Abstract][Full Text] [Related]
26. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
Hsieh CL; Gardner TA; Miao L; Balian G; Chung LW
Cancer Gene Ther; 2004 Feb; 11(2):148-55. PubMed ID: 14695756
[TBL] [Abstract][Full Text] [Related]
27. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
[TBL] [Abstract][Full Text] [Related]
28. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
[TBL] [Abstract][Full Text] [Related]
29. Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines.
Sigala S; Faraoni I; Botticini D; Paez-Pereda M; Missale C; Bonmassar E; Spano P
Clin Cancer Res; 1999 May; 5(5):1211-8. PubMed ID: 10353759
[TBL] [Abstract][Full Text] [Related]
30. Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancer.
Escara-Wilke J; Keller JM; Ignatoski KM; Dai J; Shelley G; Mizokami A; Zhang J; Yeung ML; Yeung KC; Keller ET
Prostate; 2015 Feb; 75(3):292-302. PubMed ID: 25327941
[TBL] [Abstract][Full Text] [Related]
31. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
Bonkhoff H; Remberger K
Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
[TBL] [Abstract][Full Text] [Related]
32. Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model.
Gabril MY; Onita T; Ji PG; Sakai H; Chan FL; Koropatnick J; Chin JL; Moussa M; Xuan JW
Gene Ther; 2002 Dec; 9(23):1589-99. PubMed ID: 12424611
[TBL] [Abstract][Full Text] [Related]
33. Age-related changes in the innervation of the prostate gland: implications for prostate cancer initiation and progression.
White CW; Xie JH; Ventura S
Organogenesis; 2013; 9(3):206-15. PubMed ID: 23872639
[TBL] [Abstract][Full Text] [Related]
34. Dietary fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras+myc-induced carcinomas in the mouse prostate reconstitution model system.
Slawin K; Kadmon D; Park SH; Scardino PT; Anzano M; Sporn MB; Thompson TC
Cancer Res; 1993 Oct; 53(19):4461-5. PubMed ID: 8402613
[TBL] [Abstract][Full Text] [Related]
35. Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis.
Xu J; Wang R; Xie ZH; Odero-Marah V; Pathak S; Multani A; Chung LW; Zhau HE
Prostate; 2006 Nov; 66(15):1664-73. PubMed ID: 16902972
[TBL] [Abstract][Full Text] [Related]
36. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
[TBL] [Abstract][Full Text] [Related]
37. 22 : 6n-3 DHA inhibits differentiation of prostate fibroblasts into myofibroblasts and tumorigenesis.
Bianchini F; Giannoni E; Serni S; Chiarugi P; Calorini L
Br J Nutr; 2012 Dec; 108(12):2129-37. PubMed ID: 22390897
[TBL] [Abstract][Full Text] [Related]
38. Autonomic nervous infiltration positively correlates with pathological risk grading and poor prognosis in patients with lung adenocarcinoma.
Shao JX; Wang B; Yao YN; Pan ZJ; Shen Q; Zhou JY
Thorac Cancer; 2016 Sep; 7(5):588-598. PubMed ID: 27766778
[TBL] [Abstract][Full Text] [Related]
39. A role for phospholipase C-gamma-mediated signaling in tumor cell invasion.
Kassis J; Moellinger J; Lo H; Greenberg NM; Kim HG; Wells A
Clin Cancer Res; 1999 Aug; 5(8):2251-60. PubMed ID: 10473113
[TBL] [Abstract][Full Text] [Related]
40. Autonomic innervation of the human prostate.
Vaalasti A; Hervonen A
Invest Urol; 1980 Jan; 17(4):293-7. PubMed ID: 7351361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
